Studies on antileishmanial activity of natural serine protease inhibitor s from potato tuber its role in immunomodulation and cellular invasion by leishmania donovani
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Leishmania is a complex protozoan parasite responsible for morbidity
newlineand mortality throughout the world but more adversely dominates the
newlineequatorial and tropical belt [Monzote et al, 2014]. Its digenic life form
newlineexisting as the extracellular promastigote in the sandfly vector and as the
newlineamastigote form sequestered within the phagolysosome of macrophages of
newlinethe infected mammalian host makes it a parasite of nefarious repute.
newlineLeishmania species are able to infect humans as well as other mammalian
newlinehosts (dog and rodent, etc.) and cause diseases that are known under the
newlinecommon name of leishmaniasis. The disease, leishmaniasis has high
newlineincidence and prevalence in tropical and subtropical regions of the world.
newlineThe clinical manifestations include from self-healing cutaneous (CL),
newlinemucocutaneous (MCL), an intermediary form known as
newlinePost Kala Azar
newlineDermal Leishmaniasis (PKDL) to visceral leishmaniasis (VL), the most deadly
newlineform of the disease if left improper treatment [Akhoundi et al., 2016, Oryan
newlineet al, 2018].
newlineThe current chemotherapeutic scenario of leishmaniasis is more
newlineanticipating than from past decades because of introducing both new drugs
newlineand new formulation of old drugs along with the combinational therapies
newline[Croft et al, 2006, Sundar et al, 2011]. The first line of treatment of
newlineleishmaniasis is mainly based on pentavalent antimonials (Pentostam,
newlineGlucantime) which are toxic and pretence alarm of drug resistance for more
newlinethan 50 years [Sheikhmoradi et al, 2018]. Other clinical recommendations
newlinelike, miltefosine, amphotericin B, pentamidine, paromomycin are not
newlineachieving their satisfactory grades due to harmful side-effects, toxicity and
newlinehigh cost [Rastrojo et al, 2018, Croft et al, 2006]. So the use of several
newlinenatural
newlineconsumable
newlineplant
newlineproducts
newlinewith
newlinemedicinal
newlineimplication
newlineand
newlineminimum toxicities are recommended for the treatment of various diseases
newlineincluding these types of neglected tropical diseases [Wink et al, 2012,
newlineNewman et al, 2012, Ogungbe et al, 2012]
newline